IL-2 and Mycobacterial Lipoarabinomannan as Targets of Immune Responses in Multiple Sclerosis Patients.
HERV-W
IL-2
Mycobacterium avium subsp. paratuberculosis
antibodies
autoimmune response
interleukin 2
multiple sclerosis
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
01 Apr 2020
01 Apr 2020
Historique:
received:
18
02
2020
revised:
27
03
2020
accepted:
27
03
2020
entrez:
5
4
2020
pubmed:
5
4
2020
medline:
5
4
2020
Statut:
epublish
Résumé
Interleukin 2 (IL-2) is considered a key player in exacerbating multiple sclerosis (MS). Therapies targeting its receptor have been developed; however, a resolution of the disease and side effects are still an issue of concern. The involvement of other factors, such as
Identifiants
pubmed: 32244639
pii: microorganisms8040500
doi: 10.3390/microorganisms8040500
pmc: PMC7232413
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Pediatr Diabetes. 2015 May;16(3):189-95
pubmed: 25720593
Biomedicines. 2019 Mar 11;7(1):
pubmed: 30862055
Expert Rev Clin Pharmacol. 2014 Jan;7(1):9-19
pubmed: 24308792
J Neurol Sci. 2015 Oct 15;357(1-2):106-8
pubmed: 26190523
Mult Scler. 2019 Oct;25(12):1618-1632
pubmed: 30657420
J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):339-40
pubmed: 21429904
Br Med J. 1939 May 20;1(4089):1024-1046.3
pubmed: 20782357
Ther Adv Neurol Disord. 2016 May;9(3):211-5
pubmed: 27134676
Front Microbiol. 2018 Mar 14;9:462
pubmed: 29593697
Anim Biotechnol. 2013;24(3):187-97
pubmed: 23777348
J Neuroimmunol. 2014 May 15;270(1-2):51-5
pubmed: 24642384
J Neuroimmunol. 2020 Jan 15;338:577110
pubmed: 31715457
Proc Natl Acad Sci U S A. 2019 Oct 15;116(42):21120-21130
pubmed: 31570576
Mult Scler. 2011 Nov;17(11):1282-9
pubmed: 21652610
J Exp Med. 2008 Aug 4;205(8):1763-73
pubmed: 18663124
Int J Infect Dis. 2009 Sep;13(5):e254-63
pubmed: 19303801
J Neuroimmunol. 2016 Feb 15;291:29-38
pubmed: 26857492
Clin Rev Allergy Immunol. 2010 Aug;39(1):51-61
pubmed: 19697163
Cells. 2019 Jun 04;8(6):
pubmed: 31167379
BMC Neurol. 2016 Aug 23;16(1):148
pubmed: 27552900
Expert Rev Neurother. 2013 Dec;13(12 Suppl):3-9
pubmed: 24289836
Ther Adv Neurol Disord. 2017 Jan;10(1):67-75
pubmed: 28450896
PLoS One. 2013 Dec 06;8(12):e80128
pubmed: 24324591
BMC Immunol. 2018 Nov 8;19(1):33
pubmed: 30409122
Nat Commun. 2016 Oct 06;7:13027
pubmed: 27708334
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
J Clin Neurosci. 2014 Jan;21(1):12-21
pubmed: 23916471
Vet Microbiol. 2000 Dec 20;77(3-4):465-73
pubmed: 11118731
Int Rev Immunol. 2010 Aug;29(4):351-70
pubmed: 20635879
Ther Adv Neurol Disord. 2017 Jul;10(7):265-289
pubmed: 28670343